Biological actions of drugs affecting serotonin and eating
- PMID: 8697044
- DOI: 10.1002/j.1550-8528.1995.tb00213.x
Biological actions of drugs affecting serotonin and eating
Abstract
The present status of knowledge on drugs affecting food intake and presumably acting via a serotoninergic mechanism is reviewed. The mechanism of action of these drugs is analyzed at the neurochemical level. All the drugs, to various extents, inhibit the uptake of serotonin (5HT), increase the release of 5HT and decrease brain levels of 5HT and 5HIAA. However, the underlying mechanisms are not identical as exemplified by comparisons made with d-fenfluramine, d-norfenfluramine, fluoxetine, sertraline and paroxetine. An analysis of the role of 5HT in the inhibition of food intake reveals that only d-fenfluramine is inhibited by antiserotonin agents. The role of the different 5HT receptor-subtypes in this antagonism is discussed. More selective 5HT antagonists are needed to establish which 5HT receptor(s) controls food intake.
Similar articles
-
d-Fenfluramine and salbutamol: two drugs causing anorexia through different neurochemical mechanisms.Int J Obes. 1984;8 Suppl 1:151-7. Int J Obes. 1984. PMID: 6534892
-
Progress report on the anorectic effects of dexfenfluramine, fluoxetine and sertraline.Int J Obes Relat Metab Disord. 1992 Dec;16 Suppl 3:S43-50. Int J Obes Relat Metab Disord. 1992. PMID: 1338321 Review.
-
Two novel agents affecting eating through an action on monoaminergic systems.Int J Obes. 1984;8 Suppl 1:103-17. Int J Obes. 1984. PMID: 6549508
-
The effect of the anorectic agent, d-fenfluramine, and its primary metabolite, d-norfenfluramine, on intact human platelet serotonin uptake and efflux.J Thromb Haemost. 2003 Dec;1(12):2663-8. doi: 10.1046/j.1538-7836.2003.00474.x. J Thromb Haemost. 2003. PMID: 14675103
-
Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability.Trends Pharmacol Sci. 1997 Jan;18(1):21-5. doi: 10.1016/s0165-6147(96)01003-6. Trends Pharmacol Sci. 1997. PMID: 9114726 Review.
Cited by
-
Fenfluramine-induced PVAT-dependent contraction depends on norepinephrine and not serotonin.Pharmacol Res. 2019 Feb;140:43-49. doi: 10.1016/j.phrs.2018.08.024. Epub 2018 Sep 3. Pharmacol Res. 2019. PMID: 30189295 Free PMC article.
-
Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases.Front Neurosci. 2016 Nov 24;10:541. doi: 10.3389/fnins.2016.00541. eCollection 2016. Front Neurosci. 2016. PMID: 27932945 Free PMC article. Review.
-
Molecular genetics of monoamine transporters: relevance to brain disorders.Neurochem Res. 2008 Apr;33(4):652-67. doi: 10.1007/s11064-007-9521-8. Epub 2007 Oct 25. Neurochem Res. 2008. PMID: 17960477 Review.
-
Serotonergic drugs and valvular heart disease.Expert Opin Drug Saf. 2009 May;8(3):317-29. doi: 10.1517/14740330902931524. Expert Opin Drug Saf. 2009. PMID: 19505264 Free PMC article. Review.
-
Leptin increases serotonin turnover by inhibition of brain nitric oxide synthesis.J Clin Invest. 1999 Oct;104(7):975-82. doi: 10.1172/JCI5867. J Clin Invest. 1999. PMID: 10510338 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources